investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Richard M Weinshilboum
2 Collaborator(s)
Funding source
National Institute of General Medical Sciences (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Bisrat G Debeb
Elucidate the role of miR-141 in brain metastasis from breast cancer
Breast
Hugh S. Gannon
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Breast
Gregory J Hannon
Cold Spring Harbor Laboratory Cancer Research Center
Breast
Yibin Kang
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
Breast
Li Tang
Nutrigenetics of cruciferous vegetable intake and breast cancer prognosis
Breast
Mara A Schonberg
Breast Cancer Risk Factors Among Women Aged 75 and Older
Breast
Elizabeth Mittendorf
Immunologic Aspects of Triple Negative Breast Cancer and the Effects of Neoadjuvant Systemic Therapy
Breast
Kaiyi Li
Characterization and targeting BRIT1 deficiency in breast cancer
Breast
Carol Prives
Roles and Regulation of p53
Breast
